On a mission to build the first Clinical Digital Twin Platform, accessible to everyone51-200 Employees
- B2B
- Growth StageExpanding market presence
- Top InvestorsThis company has received a significant amount of investment from top investors
- 4.2Highly ratedQ Bio is highly rated on Glassdoor, with 4.2 out of 5 stars
- Recently fundedRaised funding in the past six months
- 4.2Work / Life BalanceEmployees rate Q Bio 4.2/5 on Glassdoor for work / life balance
- 4.1Strong LeadershipEmployees rate Q Bio 4.1/5 on Glassdoor for faith in leadership
- Website
- Location
- Company size
- 51-200 people
- Company type
- Biotech
- Markets
Jobs at Q Bio
At Q Bio, our mission is to bring preventive healthcare to everyone. We believe the future of healthcare will be orders of magnitude more effective as it becomes truly data driven, preventive, and personalized. If we succeed, we see a future where treatable diseases will no longer take lives and every generation will be healthier than the last. Our first service, The Q Exam, is based on landmark systems biology research done at Stanford University. In about an hour, we take blood, saliva, urine and a non-invasive whole-body scan from which we extract 1000’s of genetic, chemical, and anatomical biomarkers to build the world’s most comprehensive quantitative snapshot of an individual’s health at a point in time. Q Bio was founded by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. We are fortunate to be backed by some of the best venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant.